258 related articles for article (PubMed ID: 17360501)
1. Urocortin 3 regulates glucose-stimulated insulin secretion and energy homeostasis.
Li C; Chen P; Vaughan J; Lee KF; Vale W
Proc Natl Acad Sci U S A; 2007 Mar; 104(10):4206-11. PubMed ID: 17360501
[TBL] [Abstract][Full Text] [Related]
2. Urocortin III is expressed in pancreatic beta-cells and stimulates insulin and glucagon secretion.
Li C; Chen P; Vaughan J; Blount A; Chen A; Jamieson PM; Rivier J; Smith MS; Vale W
Endocrinology; 2003 Jul; 144(7):3216-24. PubMed ID: 12810578
[TBL] [Abstract][Full Text] [Related]
3. Roles for corticotropin-releasing factor receptor type 1 in energy homeostasis in mice.
Sakamoto R; Matsubara E; Nomura M; Wang L; Kawahara Y; Yanase T; Nawata H; Takayanagi R
Metabolism; 2013 Dec; 62(12):1739-48. PubMed ID: 24054833
[TBL] [Abstract][Full Text] [Related]
4. Urocortin 2 modulates glucose utilization and insulin sensitivity in skeletal muscle.
Chen A; Brar B; Choi CS; Rousso D; Vaughan J; Kuperman Y; Kim SN; Donaldson C; Smith SM; Jamieson P; Li C; Nagy TR; Shulman GI; Lee KF; Vale W
Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16580-5. PubMed ID: 17050686
[TBL] [Abstract][Full Text] [Related]
5. Urocortin is not a significant regulator of intermittent electrofootshock-induced adrenocorticotropin secretion in the intact male rat.
Turnbull AV; Vaughan J; Rivier JE; Vale WW; Rivier C
Endocrinology; 1999 Jan; 140(1):71-8. PubMed ID: 9886809
[TBL] [Abstract][Full Text] [Related]
6. Urocortin II gene is highly expressed in mouse skin and skeletal muscle tissues: localization, basal expression in corticotropin-releasing factor receptor (CRFR) 1- and CRFR2-null mice, and regulation by glucocorticoids.
Chen A; Blount A; Vaughan J; Brar B; Vale W
Endocrinology; 2004 May; 145(5):2445-57. PubMed ID: 14736736
[TBL] [Abstract][Full Text] [Related]
7. Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart.
Brar BK; Jonassen AK; Egorina EM; Chen A; Negro A; Perrin MH; Mjøs OD; Latchman DS; Lee KF; Vale W
Endocrinology; 2004 Jan; 145(1):24-35; discussion 21-3. PubMed ID: 12970163
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of rat pancreatic exocrine secretion by urocortin and corticotropin releasing factor.
Guzman EA; Zhang W; Lin TR; Mulholland MW
Peptides; 2003 May; 24(5):727-34. PubMed ID: 12895659
[TBL] [Abstract][Full Text] [Related]
9. Modulation of Ca2+ influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells.
Kageyama K; Kimura R; Suga S; Ogawa Y; Suda T; Wakui M
Peptides; 2006 Jul; 27(7):1814-9. PubMed ID: 16513211
[TBL] [Abstract][Full Text] [Related]
10. Urocortin, corticotropin releasing factor-2 receptors and energy balance.
Cullen MJ; Ling N; Foster AC; Pelleymounter MA
Endocrinology; 2001 Mar; 142(3):992-9. PubMed ID: 11181511
[TBL] [Abstract][Full Text] [Related]
11. Role of urocortin 2 secreted by the pituitary in the stress-induced suppression of luteinizing hormone secretion in rats.
Nemoto T; Iwasaki-Sekino A; Yamauchi N; Shibasaki T
Am J Physiol Endocrinol Metab; 2010 Oct; 299(4):E567-75. PubMed ID: 20663987
[TBL] [Abstract][Full Text] [Related]
12. Urocortins and corticotropin releasing factor type 2 receptors in the hypothalamus and the cardiovascular system.
Hashimoto K; Nishiyama M; Tanaka Y; Noguchi T; Asaba K; Hossein PN; Nishioka T; Makino S
Peptides; 2004 Oct; 25(10):1711-21. PubMed ID: 15476938
[TBL] [Abstract][Full Text] [Related]
13. Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors.
Bittencourt JC; Vaughan J; Arias C; Rissman RA; Vale WW; Sawchenko PE
J Comp Neurol; 1999 Dec; 415(3):285-312. PubMed ID: 10553117
[TBL] [Abstract][Full Text] [Related]
14. Urocortin 3 transgenic mice exhibit a metabolically favourable phenotype resisting obesity and hyperglycaemia on a high-fat diet.
Jamieson PM; Cleasby ME; Kuperman Y; Morton NM; Kelly PA; Brownstein DG; Mustard KJ; Vaughan JM; Carter RN; Hahn CN; Hardie DG; Seckl JR; Chen A; Vale WW
Diabetologia; 2011 Sep; 54(9):2392-403. PubMed ID: 21667214
[TBL] [Abstract][Full Text] [Related]
15. Injection of Urocortin 3 into the ventromedial hypothalamus modulates feeding, blood glucose levels, and hypothalamic POMC gene expression but not the HPA axis.
Chen P; Vaughan J; Donaldson C; Vale W; Li C
Am J Physiol Endocrinol Metab; 2010 Feb; 298(2):E337-45. PubMed ID: 19952342
[TBL] [Abstract][Full Text] [Related]
16. Systemic urocortin 2, but not urocortin 1 or stressin 1-A, suppresses feeding via CRF2 receptors without malaise and stress.
Fekete EM; Zhao Y; Szücs A; Sabino V; Cottone P; Rivier J; Vale WW; Koob GF; Zorrilla EP
Br J Pharmacol; 2011 Dec; 164(8):1959-75. PubMed ID: 21627635
[TBL] [Abstract][Full Text] [Related]
17. Expression of urocortin and corticotropin-releasing factor receptor subtypes in the human heart.
Kimura Y; Takahashi K; Totsune K; Muramatsu Y; Kaneko C; Darnel AD; Suzuki T; Ebina M; Nukiwa T; Sasano H
J Clin Endocrinol Metab; 2002 Jan; 87(1):340-6. PubMed ID: 11788672
[TBL] [Abstract][Full Text] [Related]
18. Modulation of urocortin-induced hypophagia and weight loss by corticotropin-releasing factor receptor 1 deficiency in mice.
Bradbury MJ; McBurnie MI; Denton DA; Lee KF; Vale WW
Endocrinology; 2000 Aug; 141(8):2715-24. PubMed ID: 10919255
[TBL] [Abstract][Full Text] [Related]
19. Urocortin 2 expression in the rat gastrointestinal tract under basal conditions and in chemical colitis.
Chang J; Hoy JJ; Idumalla PS; Clifton MS; Pecoraro NC; Bhargava A
Peptides; 2007 Jul; 28(7):1453-60. PubMed ID: 17586086
[TBL] [Abstract][Full Text] [Related]
20. The neurobiology of urocortin.
Skelton KH; Owens MJ; Nemeroff CB
Regul Pept; 2000 Sep; 93(1-3):85-92. PubMed ID: 11033056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
